Skip to main navigation
CareDx
  • COMPANY
    • Management Team
    • Board of Directors
    • Compliance
    • Careers
      • Current Openings
      • Benefits
  • PRODUCTS
    • HeartCare, AlloMap
    • KidneyCare, AlloSure
    • Laboratory Products
    • Ottr
  • INVESTORS
  • CONTACT US

Press Releases

Media Inquiries - media@caredxinc.com
Date Title and Summary Additional Formats
Toggle Summary Jul 13, 2017 100,000th AlloMap Result Provided to Heart Transplant Patients
BRISBANE, Calif. , July 13, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focusing on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announced today that the landmark
View HTML
100,000th AlloMap Result Provided to Heart Transplant Patients 19.8 KB
Toggle Summary May 03, 2019 AlloMap In-Network with Anthem Blue Cross
AlloMap now in-network for over 80% of covered lives with all US payors BRISBANE, Calif. , May 03, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic
View HTML
Toggle Summary Sep 22, 2017 AlloMap's Medicare reimbursement to increase in 2018
PAMA to provide pricing certainty for high value diagnostic testing
View HTML
AlloMap's Medicare reimbursement to increase in 2018 19.8 KB
Toggle Summary Oct 30, 2017 AlloSure data will be presented at ASN
CareDx further bolsters clinical evidence
View HTML
AlloSure data will be presented at ASN 17.5 KB
Toggle Summary Nov 18, 2016 AlloSure Detects Active Rejection in Kidney Transplant Patients
Late-breaking DART data presented at ASN meeting in Chicago
View HTML
AlloSure Detects Active Rejection in Kidney Transplant Patients 23.8 KB
Toggle Summary Mar 14, 2017 AlloSure Featured in Journal of Applied Laboratory Medicine
Defines Cell-free DNA Levels in Stable Kidney Transplant Patients
View HTML
AlloSure Featured in Journal of Applied Laboratory Medicine 27.8 KB
Toggle Summary Mar 09, 2017 AlloSure Featured in Journal of the American Society of Nephrology
Cell-free-DNA test identifies active rejection in kidney transplant patients
View HTML
AlloSure Featured in Journal of the American Society of Nephrology 28.8 KB
Toggle Summary Aug 22, 2019 AlloSure for Heart Transplant Patients Receives CMS Draft Coverage
CareDx expands leadership with cfDNA for transplant care BRISBANE, Calif. , Aug. 22, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions
View HTML
Toggle Summary Mar 11, 2019 AlloSure Heart Clinical Validation Published in Leading Transplant Journal
Alongside AlloSure Heart Validation, CareDx advances SHORE enrollment    BRISBANE, Calif. , March 11, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value
View HTML
Toggle Summary Feb 21, 2019 AlloSure now available for Lung Transplant Patients
New data highlights the value of AlloSure to detect rejection in one of the most complex transplanted organs BRISBANE, Calif. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Next page Next
  • Last page Last
Displaying 1 - 10 of 285 results

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Printed Materials
E-mail Alerts
Downloads
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

    ©2004-2017 CareDx, Inc. All Rights Reserved.    CareDx is a registered trademark of CareDx, Inc.

    Privacy & Compliance